Home > Insider Trading > Filing (0001209191-19-025791)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595893	Turning Point Therapeutics Inc.	TPTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1282930	L Carl Gordon	C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 225 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-22	1,120,730	$0.00	1,120,730	No	4	C	Indirect	By OrbiMed Private Investments VI, LP
Common Stock	Acquisiton	2019-04-22	546,820	$0.00	1,667,550	No	4	C	Indirect	By OrbiMed Private Investments VI, LP
Common Stock	Acquisiton	2019-04-22	360,000	$18.00	2,027,550	No	4	P	Indirect	By OrbiMed Private Investments VI, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By OrbiMed Private Investments VI, LP
No	4	C	Indirect	By OrbiMed Private Investments VI, LP
No	4	P	Indirect	By OrbiMed Private Investments VI, LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2019-04-22	15,000	$0.00	15,000	$27.06
Common Stock	Series C Preferred Stock	Disposition	2019-04-22	4,314,809	$0.00	1,120,730	$0.00
Common Stock	Series D Preferred Stock	Disposition	2019-04-22	2,105,259	$0.00	546,820	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,000	2029-04-21	No	4	A	Direct
0		No	4	C	Indirect
0		No	4	C	Indirect

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of each share of preferred stock into 0.25974026 shares of common stock. The shares have no expiration date.
OrbiMed Capital GP VI LLC (GP VI) is the general partner of OrbiMed Private Investments VI, LP. (OPI VI). OrbiMed Advisors LLC (OrbiMed Advisors) is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VI and as a result may be deemed to have beneficial ownership of such shares. The Reporting Person is a member of OrbiMed Advisors. OrbiMed Advisors exercise investment and voting power through a management committee comprised of the Reporting Person, Sven H. Borho and Jonathan T. Silverstein. Each of GP VI, OrbiMed Advisors and the Reporting Person disclaims beneficial ownership of the shares held by OPI VI, except to the extent of its or his pecuniary interest therein if any.
The shares were purchased at the Issuer's initial public offering.
The option will become fully vested on the date of the Issuer's 2020 annual meeting of stockholders.